Plasma Epstein-Barr Virus Load as an Early Biomarker and Prognostic Factor of Human Immunodeficiency Virus–related Lymphomas

Josep Muncunill(Universitat Autònoma de Barcelona), José‐Tomás Navarro(Universitat Autònoma de Barcelona), Evarist Feliú(Universitat Autònoma de Barcelona), José Luís Mate(Universitat Autònoma de Barcelona), Judith Dalmau, Gustavo Tapia(Hospital Universitari Germans Trias i Pujol), Javier Martínez‐Picado(Universitat de Vic - Universitat Central de Catalunya), Juan‐Manuel Sancho(Hospital Universitari Germans Trias i Pujol), Josep‐María Ribera(Universitat Autònoma de Barcelona), Maria João Baptista(Josep Carreras Leukaemia Research Institute), Miriam Moreno(Universitat Autònoma de Barcelona), Olga García(Universitat Autònoma de Barcelona), Àgueda Hernández-Rodríguez(Universitat Autònoma de Barcelona)
Clinical Infectious Diseases
June 28, 2018
10.1093/cid/ciy542
Cited by 16

Related Papers

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2016|457
Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL
|Blood|2016|329
Influence of Pre- and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma: Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer Survival
|Journal of Clinical Oncology|2008|282
Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Espanol de Linfomas/Trasplante de Medula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
|Haematologica|2011|215